
An international team of medical researchers has discovered a previously hidden biological mechanism that allows high-cholesterol diets to actively disable the body’s natural defenses against harmful lipids. According to the published study, blocking this newly identified pathway completely restored natural regulation and dramatically lowered harmful LDL cholesterol levels in animal models. Most significantly, an experimental drug designed to target this specific driver has already successfully passed its initial human safety testing phase, paving the way for a revolutionary class of cardiovascular therapies that could hit the market much faster than expected.